Bioton S.A.
BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; oral diabetic drugs; strips for measuring sugar in blood, as well as Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes m… Read more
Bioton S.A. (BIO) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.017x
Based on the latest financial reports, Bioton S.A. (BIO) has a cash flow conversion efficiency ratio of 0.017x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł9.98 Million) by net assets (zł588.01 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Bioton S.A. - Cash Flow Conversion Efficiency Trend (2005–2024)
This chart illustrates how Bioton S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Bioton S.A. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bioton S.A. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Mifflinburg Bancorp Inc
PINK:MIFF
|
-0.168x |
|
Fortune Information Systems Corp
TW:2468
|
0.088x |
|
Australian Strategic Materials Ltd
PINK:ASMMF
|
-0.036x |
|
0FUW
LSE:0FUW
|
N/A |
|
Arctic Paper SA
WAR:ATC
|
0.015x |
|
Nabaltec AG
F:NTG
|
0.050x |
|
MICROPOLE S.A.INH. EO-05
F:MP4
|
N/A |
|
BIT Computer Co. Ltd
KQ:032850
|
0.031x |
Annual Cash Flow Conversion Efficiency for Bioton S.A. (2005–2024)
The table below shows the annual cash flow conversion efficiency of Bioton S.A. from 2005 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | zł590.55 Million | zł36.33 Million | 0.062x | -5.86% |
| 2023-12-31 | zł606.36 Million | zł39.62 Million | 0.065x | -29.38% |
| 2022-12-31 | zł606.06 Million | zł56.08 Million | 0.093x | +943.56% |
| 2021-12-31 | zł622.74 Million | zł5.52 Million | 0.009x | -86.90% |
| 2020-12-31 | zł619.64 Million | zł41.95 Million | 0.068x | -15.64% |
| 2019-12-31 | zł582.00 Million | zł46.71 Million | 0.080x | +105.18% |
| 2018-12-31 | zł712.79 Million | zł27.88 Million | 0.039x | +72.80% |
| 2017-12-31 | zł773.25 Million | zł17.50 Million | 0.023x | -20.41% |
| 2016-12-31 | zł813.83 Million | zł23.15 Million | 0.028x | -4.50% |
| 2015-12-31 | zł806.64 Million | zł24.02 Million | 0.030x | +2.81% |
| 2014-12-31 | zł1.45 Billion | zł41.87 Million | 0.029x | -49.82% |
| 2013-12-31 | zł1.39 Billion | zł79.96 Million | 0.058x | -46.71% |
| 2012-12-31 | zł1.34 Billion | zł144.80 Million | 0.108x | +775.77% |
| 2011-12-31 | zł1.38 Billion | zł-22.20 Million | -0.016x | -169.02% |
| 2010-12-31 | zł1.17 Billion | zł27.17 Million | 0.023x | +131.27% |
| 2009-12-31 | zł1.08 Billion | zł-80.22 Million | -0.074x | -343.58% |
| 2008-12-31 | zł1.24 Billion | zł37.74 Million | 0.030x | +5202.64% |
| 2007-12-31 | zł886.79 Million | zł-530.00K | -0.001x | +95.51% |
| 2006-12-31 | zł808.11 Million | zł-10.76 Million | -0.013x | -147.73% |
| 2005-12-31 | zł255.42 Million | zł7.13 Million | 0.028x | -- |